Research ArticleArticle
Equivalent Responses to Disease-modifying Antirheumatic Drugs Initiated at Any Time During the First 15 Months After Symptom Onset in Patients with Seropositive Rheumatoid Arthritis
Haoling H. Weng, Veena K. Ranganath, Dinesh Khanna, Myungshin Oh, Daniel E. Furst, Grace S. Park, David A. Elashoff, John T. Sharp, Richard H. Gold, James B. Peter, Harold E. Paulus and the Western Consortium of Practicing Rheumatologists
The Journal of Rheumatology January 2010, jrheum.090818; DOI: https://doi.org/10.3899/jrheum.090818
Haoling H. Weng
Veena K. Ranganath
Dinesh Khanna
Myungshin Oh
Daniel E. Furst
Grace S. Park
David A. Elashoff
John T. Sharp
Richard H. Gold
James B. Peter
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Equivalent Responses to Disease-modifying Antirheumatic Drugs Initiated at Any Time During the First 15 Months After Symptom Onset in Patients with Seropositive Rheumatoid Arthritis
Haoling H. Weng, Veena K. Ranganath, Dinesh Khanna, Myungshin Oh, Daniel E. Furst, Grace S. Park, David A. Elashoff, John T. Sharp, Richard H. Gold, James B. Peter, Harold E. Paulus, the Western Consortium of Practicing Rheumatologists
The Journal of Rheumatology Jan 2010, jrheum.090818; DOI: 10.3899/jrheum.090818
Equivalent Responses to Disease-modifying Antirheumatic Drugs Initiated at Any Time During the First 15 Months After Symptom Onset in Patients with Seropositive Rheumatoid Arthritis
Haoling H. Weng, Veena K. Ranganath, Dinesh Khanna, Myungshin Oh, Daniel E. Furst, Grace S. Park, David A. Elashoff, John T. Sharp, Richard H. Gold, James B. Peter, Harold E. Paulus, the Western Consortium of Practicing Rheumatologists
The Journal of Rheumatology Jan 2010, jrheum.090818; DOI: 10.3899/jrheum.090818